title: ATM stabilizes DNA double-strand-break complexes during V(D)J recombination.
abstract: The ATM (ataxia-telangiectasia mutated) protein kinase mediates early cellular responses to DNA double-strand breaks (DSBs) generated during metabolic processes or by DNA-damaging agents. ATM deficiency leads to ataxia-telangiectasia, a disease marked by lymphopenia, genomic instability and an increased predisposition to lymphoid malignancies with chromosomal translocations involving lymphocyte antigen receptor loci. ATM activates cell-cycle checkpoints and can induce apoptosis in response to DNA DSBs. However, defects in these pathways of the DNA damage response cannot fully account for the phenotypes of ATM deficiency. Here, we show that ATM also functions directly in the repair of chromosomal DNA DSBs by maintaining DNA ends in repair complexes generated during lymphocyte antigen receptor gene assembly. When coupled with the cell-cycle checkpoint and pro-apoptotic activities of ATM, these findings provide a molecular explanation for the increase in lymphoid tumours with translocations involving antigen receptor loci associated with ataxia-telangiectasia.
authors.affiliation: Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri 63110, USA.
authors.forename: Andrea L
authors.initials: AL
authors.lastname: Bredemeyer
authors.forename: Girdhar G
authors.initials: GG
authors.lastname: Sharma
authors.forename: Ching-Yu
authors.initials: CY
authors.lastname: Huang
authors.forename: Beth A
authors.initials: BA
authors.lastname: Helmink
authors.forename: Laura M
authors.initials: LM
authors.lastname: Walker
authors.forename: Katrina C
authors.initials: KC
authors.lastname: Khor
authors.forename: Beth
authors.initials: B
authors.lastname: Nuskey
authors.forename: Kathleen E
authors.initials: KE
authors.lastname: Sullivan
authors.forename: Tej K
authors.initials: TK
authors.lastname: Pandita
authors.forename: Craig H
authors.initials: CH
authors.lastname: Bassing
authors.forename: Barry P
authors.initials: BP
authors.lastname: Sleckman
mesh_terms: D000818:Animals; D001260:Ataxia Telangiectasia / Q000235:genetics; D064007:Ataxia Telangiectasia Mutated Proteins; D001402:B-Lymphocytes / Q000378:metabolism; D018797:Cell Cycle Proteins / Q000235:genetics / Q000378:metabolism*; D002460:Cell Line; D019457:Chromosome Breakage / Q000235:genetics; D004249:DNA Damage; D004260:DNA Repair; D004268:DNA-Binding Proteins / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D015322:Gene Rearrangement, B-Lymphocyte / Q000235:genetics*; D051379:Mice; D017346:Protein Serine-Threonine Kinases / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D013234:Stem Cells / Q000378:metabolism; D025521:Tumor Suppressor Proteins / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*
chemical_list: D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D025521:Tumor Suppressor Proteins; D064007:Ataxia Telangiectasia Mutated Proteins; C576325:Atm protein, mouse; D017346:Protein Serine-Threonine Kinases